Latest Stories
Guest Editorial
The shortage of certain cancer drugs is a serious and life-threatening issue for cancer patients across the United States. This, however, is not a new issue. Drug shortages are a cyclical event, and we need a durable solution to ensure that cancer patients have access to the drugs and the treatment they need to survive.
FreeGuest Editorial
The American Cancer Society’s key stakeholders are people with cancer and their families.
FreeGuest Editorial
Diversity, inclusion, and equity are important issues, not only to our nation's cancer centers, but to our nation as a whole. To embody these values, we must work to close gaps in cancer research and care.
COVID-19 & CancerFreeGuest Editorial
This story is part of The Cancer Letter's ongoing coverage of COVID-19's impact on oncology. A full list of our coverage, as well as the latest meeting cancellations, is available here.As COVID-19 has now officially been declared a source of the pandemic, with increasing incidence across the nation, it is without question that the needs of patients with particular vulnerabilities should garner particular attention.
Guest Editorial
If enacted, the proposed budget reduction of $5.8 billion to the National Institutes of Health will slow research, deprive patients afflicted with cancer of hope, and deliver a devastating blow to our science workforce and the Commonwealth of Pennsylvania. This proposed reduction directly counters the wisdom of the U.S. Congress, who less than a year ago overwhelmingly passed the 21st Century Cures Act.
